Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
about
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyImpaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of InfectionBax inhibitor-1 down-regulation in the progression of chronic liver diseases.Hepatocyte death: a clear and present danger.Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma.Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children.Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.Foxp3 expression in liver correlates with the degree but not the cause of inflammation.The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.Polymorphisms within Fas gene are not associated with occult hepatitis B virus infection: Polymorphisms within Fas gene in occult HBV infectionDonor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection.Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis.Increased A20 mRNA Level in Peripheral Blood Mononuclear Cells is Associated With Immune Phases of Patients With Chronic Hepatitis B.AIM2 mediates inflammation-associated renal damage in hepatitis B virus-associated glomerulonephritis by regulating caspase-1, IL-1β, and IL-18.Hepatitis regulation by the inflammasome signaling pathway.Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma.Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.CD205-TLR9-IL-12 axis contributes to CpG-induced oversensitive liver injury in HBsAg transgenic mice by promoting the interaction of NKT cells with Kupffer cells.FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection.The relationship between hepatitis B virus (HBV) load and levels of transforming growth factor beta 1 (TGF-β1) and soluble Fas (sFas) in human immunodeficiency virus patients with occult HBV infection.TGF-beta1 gene silencing for treating liver fibrosis.The role of fas/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma.Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCCReplication of hepatitis E virus in the ovary and promotion of oocyte apoptosis in rabbits infected with HEV-4.Association Between Polymorphisms of Interleukin 1 Family Genes and Hepatocellular Carcinoma.
P2860
Q27005850-C5962D77-A2BC-4A0B-9404-346F602E2E2DQ27487035-248BF94E-7BA9-437A-867C-9F4770DE17EDQ33548519-2C74AEF2-481B-4D61-84EE-5D0C237355A2Q34147508-807311B4-DD31-4707-945A-E2C1B9C58517Q34396410-4DF48141-CF43-4556-94F7-DCE8D06CA1D9Q34551475-1DE96668-90A5-4813-91AF-49345835E23DQ34673075-FBC93E13-B576-4369-B3B6-34AADEB93028Q34795394-CFD49475-DA57-4A7C-8D4E-93A8ADF6ED62Q35104601-1764944D-87A6-4758-AEB2-56FE11E80186Q35136610-9379E332-9AE7-414D-BCB4-E2E27F465316Q35507186-007523BC-B914-4D0A-940B-7EDE35B39377Q35570778-D48181AD-1454-4D60-91ED-F8D28A5D1004Q36034835-2BFC2AB5-888B-4DC2-BAD8-104952666721Q36979114-EB495A8F-C36B-4D08-8EEA-BC6FC65E0BA8Q37300472-A9E002CD-EBE2-4925-BF3C-8041068CB687Q37624280-CD5D859F-8300-4D3D-9D28-73730D9730F7Q37631457-AE76F4B8-0C57-4AB6-AA38-2EC98DE2ADE6Q38423384-89D3EC59-09D8-4B2F-BC7A-F8E214BF4AC0Q39402166-E4C6E4E5-EA68-4FFA-8445-A5B9C721A32FQ39586226-795198CC-F2D1-4268-96FC-4050BB248BADQ39866521-DFE0B78A-F99A-4A9A-B0E1-07D29579BB1FQ40902779-627AF831-C358-49C8-AA01-312DA934BDA2Q41216443-CA4AD6DF-18B4-4606-8357-E112F49E9086Q42215330-BDA30765-459A-48B1-926F-630740BBD3DBQ42557392-62FF8C70-7098-4340-A0E9-6F5A7E8DD688Q43035535-EBA81929-C18A-4B7D-ACFF-88D052D4C273Q44258365-4424C85C-9A73-4594-96D7-4EB6970700A2Q46946895-375C4EF8-777F-4212-86D3-CFECCCCD7967Q50021143-CF9D9A13-60DF-4E39-90B6-50419FD562A6Q55261565-CB41F02C-AC2F-41CD-BA74-7D25CCD3B789
P2860
Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Fas / FasL system, IL-1beta ex ...... nic HBV and HCV liver disease.
@en
Fas / FasL system, IL-1beta ex ...... nic HBV and HCV liver disease.
@nl
type
label
Fas / FasL system, IL-1beta ex ...... nic HBV and HCV liver disease.
@en
Fas / FasL system, IL-1beta ex ...... nic HBV and HCV liver disease.
@nl
prefLabel
Fas / FasL system, IL-1beta ex ...... nic HBV and HCV liver disease.
@en
Fas / FasL system, IL-1beta ex ...... nic HBV and HCV liver disease.
@nl
P2093
P1476
Fas / FasL system, IL-1beta ex ...... nic HBV and HCV liver disease.
@en
P2093
P304
P356
10.1111/J.1365-2893.2008.00974.X
P577
2008-03-06T00:00:00Z